Safety and Pharmacokinetics of AS-101 with Zidovudine in AIDS/ARC Patients

This study focuses on examining the safety and effectiveness of a drug called AS-101 when used together with another drug, Zidovudine (AZT), in patients diagnosed with AIDS or AIDS Related Complex (ARC). The main goal is to understand how this combination therapy works for these patients and how it might potentially improve their treatment. The study is particularly important as it aims to address the challenges faced in managing AIDS and ARC, and could pave the way for better care strategies for those affected by these conditions. During the study, participants will receive different dosages of AS-101 along with Zidovudine (AZT). The researchers will monitor various aspects such as how the body responds to these drugs, how the drugs interact within the body, and the impact of this combination on the immune system. They will also gather data related to neurocognitive functions. The study is designed to ensure the safety of the participants while gathering crucial information about the effectiveness of this combined treatment approach.